AtaiBeckley (ATAI) Total Current Liabilities (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly Total Current Liabilities of $25.0 million in Q1 2026, up 6.32% quarter-over-quarter from $23.5 million in Q4 2025.
AtaiBeckley (ATAI) Total Current Liabilities (2020 - 2026) Analysis & Trends
AtaiBeckley's Total Current Liabilities history runs 3 years deep, the most recent figure standing at $25.0 million for Q1 2026.
- In Q1 2026, Total Current Liabilities changed N/A year-over-year to $25.0 million; the TTM figure through Mar 2026 stood at $25.0 million (changed N/A YoY), while the FY2025 annual figure was $23.5 million, down 5.9% from the prior year.
- Total Current Liabilities was $25.0 million for Q1 2026 at AtaiBeckley, up from $23.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $28.5 million in Q1 2025 to a low of $14.2 million in Q2 2021.
- The 5-year median for Total Current Liabilities is $19.9 million (2022), against an average of $20.3 million.
- Biggest YoY gain for Total Current Liabilities was 5.9% in 2025; the steepest drop was 5.9% in 2025.
- A 3-year view of Total Current Liabilities shows it stood at $25.0 million in 2024, then declined by 5.9% to $23.5 million in 2025, then gained by 6.32% to $25.0 million in 2026.
- The last three Total Current Liabilities figures came in at $25.0 million (Q1 2026), $23.5 million (Q4 2025), and $25.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | 24.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.96 Mn |
| Dec 31, 2025 | 23.48 Mn |
| Sep 30, 2025 | 16.54 Mn |
| Jun 30, 2025 | 25.55 Mn |
| Mar 31, 2025 | 28.50 Mn |
| Dec 31, 2024 | 24.95 Mn |
| Dec 31, 2024 | 24.95 Mn |
| Sep 30, 2024 | 19.64 Mn |
| Jun 30, 2024 | 17.64 Mn |
| Mar 31, 2024 | 15.01 Mn |
| Dec 31, 2023 | 20.12 Mn |
| Sep 30, 2023 | 19.70 Mn |
| Jun 30, 2023 | 17.93 Mn |
| Mar 31, 2023 | 19.95 Mn |
| Dec 31, 2022 | 19.90 Mn |
| Sep 30, 2022 | 25.91 Mn |
| Jun 30, 2022 | 21.96 Mn |
| Mar 31, 2022 | 22.09 Mn |
| Dec 31, 2021 | 20.94 Mn |
| Sep 30, 2021 | 15.32 Mn |